X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.83 -0.07 (-2.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Cash from Financing Activities (2017 - 2026)

Updated

X4 Pharmaceuticals' Cash from Financing Activities was $75,000 in Q2 2026, down 98.7% from $5.63 million a year earlier.

Analysis

X4 Pharmaceuticals (XFOR) Cash from Financing Activities (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, X4 Pharmaceuticals' Cash from Financing Activities was $233.07 million through Jun 30, 2026; for FY2025, it was $238.63 million.

  • Cash from Financing Activities shows a five-year compound annual growth rate of 80.7% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $20.29 million in FY2024 (-77.1%), $88.52 million in FY2023 (-24.5%), $117.23 million in FY2022 (+57.9%) and $74.25 million in FY2021 (+499.0%).
  • Quarterly Cash from Financing Activities has moved between -$4.44 million (Q3 2021) and $146.09 million (Q4 2025) over five years.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q4 2021 (growth of 222.1%); the worst was Q4 2023 (a decline of 99.8%).
  • Per Business Quant data, XFOR's Cash from Financing Activities in the three quarters before Q2 2026 was $2,000 (Q1 2026), $146.09 million (Q4 2025) and $86.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 X4 Pharmaceuticals 366.40 Mn -332.29 Mn 7.19 Mn 75,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 146.09 Mn
Sep 30, 2025 86.91 Mn
Jun 30, 2025 5.63 Mn
Dec 31, 2024 135,000.00
Jun 30, 2024 20.16 Mn
Dec 31, 2023 97,000.00
Sep 30, 2023 21.21 Mn
Jun 30, 2023 69.34 Mn
Mar 31, 2023 -2.12 Mn
Dec 31, 2022 60.64 Mn
Sep 30, 2022 51.98 Mn
Jun 30, 2022 -347,000.00
Mar 31, 2022 4.96 Mn
Dec 31, 2021 24.57 Mn
Sep 30, 2021 -4.44 Mn
Jun 30, 2021 -924,000.00
Mar 31, 2021 55.04 Mn
Dec 31, 2020 7.63 Mn
API Access

X4 Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=XFOR&period=max&api_key=YOUR_API_KEY